Abeona Therapeutics (ABEO) Assets (2010 - 2026)
Abeona Therapeutics (ABEO) recorded Assets of $179.51 million in Q2 2026, down 27.1% from $246.23 million a year earlier and down 9.6% from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Abeona Therapeutics reported Assets of $219.57 million, up 101.6% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $108.93 million in FY2024 (+70.2%), $64 million in FY2023 (-0.3%), $64.21 million in FY2022 (-19.3%) and $79.59 million in FY2021 (-47.4%).
- The Q2 2026 figure is the lowest quarterly Assets since Q1 2025.
- On a year-over-year basis, Assets rose in seven of the last eight quarters, with growth averaging 66.9%.
- Peak year-over-year performance for Assets in the last five years was growth of 150.2% in Q2 2024, against a decline of 67.4% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $198.49 million (Q1 2026), $219.57 million (Q4 2025) and $231.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Abeona Therapeutics | 302.73 Mn | -411.23 Mn | 7.20 Mn | 179.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 179.51 Mn |
| Mar 31, 2026 | 198.49 Mn |
| Dec 31, 2025 | 219.57 Mn |
| Sep 30, 2025 | 231.10 Mn |
| Jun 30, 2025 | 246.23 Mn |
| Mar 31, 2025 | 99.36 Mn |
| Dec 31, 2024 | 108.93 Mn |
| Sep 30, 2024 | 120.59 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 74.83 Mn |
| Dec 31, 2023 | 64.00 Mn |
| Sep 30, 2023 | 66.09 Mn |
| Jun 30, 2023 | 53.55 Mn |
| Mar 31, 2023 | 53.35 Mn |
| Dec 31, 2022 | 64.21 Mn |
| Sep 30, 2022 | 38.76 Mn |
| Jun 30, 2022 | 44.72 Mn |
| Mar 31, 2022 | 55.17 Mn |
| Dec 31, 2021 | 79.59 Mn |
| Sep 30, 2021 | 119.02 Mn |
API Access
Abeona Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();